Display options
Cite
Bauer V. Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum. Br J Pharmacol. 1985;85(1):171-7doi: 10.1111/j.1476-5381.1985.tb08844.x.
Bauer, V. (1985). Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum. British journal of pharmacology, 85(1), 171-7. https://doi.org/10.1111/j.1476-5381.1985.tb08844.x
Bauer, V. "Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum." British journal of pharmacology vol. 85,1 (1985): 171-7. doi: https://doi.org/10.1111/j.1476-5381.1985.tb08844.x
Bauer V. Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum. Br J Pharmacol. 1985 May;85(1):171-7. doi: 10.1111/j.1476-5381.1985.tb08844.x. PMID: 2411318; PMCID: PMC1916749.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1985 May;85(1):171-7. doi: 10.1111/j.1476-5381.1985.tb08844.x.

Effects of 3,4-diaminopyridine and tetraethylammonium on the pre- and post-junctional alpha-adrenoceptor mediated inhibitory actions of noradrenaline in the guinea-pig ileum.

British journal of pharmacology

V Bauer

PMID: 2411318 PMCID: PMC1916749 DOI: 10.1111/j.1476-5381.1985.tb08844.x
Free PMC Article

Abstract

The effects of potassium channel blockers, 3,4-diaminopyridine (DAP) and tetraethylammonium (TEA) were studied on the pre- and post-junctional alpha 2-adrenoceptor mediated effects of noradrenaline in the guinea-pig proximal ileum. Both DAP (4 to 500 mumol l-1) and TEA (0.3 to 3 mmol l-1) transiently increased the basal tension of the ileum. However, DAP also increased the amplitude of the smooth muscle twitches evoked by transmural nerve stimulation, whereas TEA marginally depressed them. Atropine (2 mumol l-1) antagonized the contractions induced by DAP but did not affect the similar effects of TEA. On the other hand, DAP restored the smooth muscle twitches depressed by atropine, while TEA did not. DAP, in a concentration-dependent manner, reduced or abolished the prejunctional inhibitory alpha 2-adrenoceptor mediated effect of noradrenaline, whereas TEA (up to 3 mmol l-1) was almost ineffective. The postjunctional inhibitory alpha 2-adrenoceptor mediated effect of noradrenaline was attenuated even at the smallest TEA concentration used (0.3 mmol l-1) and its postjunctional stimulatory alpha 1-adrenoceptor mediated effect was unmasked. However, DAP, was only marginally effective, even at the highest concentrations used (100 and 500 mumol l-1). From these results it would appear that in both the pre- and post-junctional inhibitory alpha 2-adrenoceptor mediated actions of noradrenaline in the guinea-pig ileum the primary step might be an increased potassium conductance. However, the potassium channels on the neuronal and the smooth muscle membrane have different sensitivities to DAP and TEA.

References

  1. Eur J Pharmacol. 1977 Apr 21;42(4):411-2 - PubMed
  2. Proc R Soc Lond B Biol Sci. 1969 Mar 11;172(1027):103-19 - PubMed
  3. Br J Pharmacol. 1970 Jun;39(2):398-413 - PubMed
  4. Br J Pharmacol. 1980 Jul;69(3):453-60 - PubMed
  5. Br J Pharmacol. 1982 Aug;76(4):603-11 - PubMed
  6. Br J Pharmacol. 1981 Feb;72(2):201-10 - PubMed
  7. Fiziol Zh. 1967 Jan-Feb;13(1):3-11 - PubMed
  8. Prog Neurobiol. 1979;12(3-4):181-290 - PubMed
  9. Am J Physiol. 1980 Nov;239(5):C182-9 - PubMed
  10. Nature. 1974 Aug 2;250(465):432-3 - PubMed
  11. Annu Rev Biophys Bioeng. 1978;7:1-18 - PubMed
  12. Pharmacol Rev. 1978 Jun;30(2):209-45 - PubMed
  13. J Physiol. 1955 Feb 28;127(2):40-1P - PubMed
  14. J Gen Physiol. 1965 May;48:859-72 - PubMed
  15. Br J Pharmacol. 1969 Jan;35(1):10-28 - PubMed
  16. Naunyn Schmiedebergs Arch Pharmacol. 1982 May;319(2):115-20 - PubMed
  17. J Pharmacol Exp Ther. 1959 Oct;127:146-9 - PubMed
  18. Jpn J Physiol. 1980;30(3):473-85 - PubMed
  19. Neuroscience. 1982 Feb;7(2):315-25 - PubMed
  20. Am J Physiol. 1979 Nov;237(5):C247-56 - PubMed
  21. Br J Pharmacol Chemother. 1966 Dec;28(3):296-307 - PubMed
  22. J Physiol. 1979 Dec;297(0):443-62 - PubMed
  23. Life Sci. 1977 Sep 1;21(5):683-94 - PubMed
  24. J Physiol. 1980 Aug;305:235-48 - PubMed
  25. Eur J Pharmacol. 1982 Dec 17;86(1):111-5 - PubMed
  26. J Gen Physiol. 1967 May;50(5):1287-302 - PubMed
  27. Br J Pharmacol. 1982 Aug;76(4):569-78 - PubMed
  28. Acta Physiol Scand. 1978 Jul;103(3):225-39 - PubMed
  29. Br J Pharmacol. 1981 Oct;74(2):419-28 - PubMed
  30. Br J Pharmacol. 1976 Mar;56(3):331-8 - PubMed
  31. Br J Pharmacol. 1979 Mar;65(3):435-45 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources